Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 16 Beta-ethyl-17 Beta-hydroxyestr-4-en-3-one
2. 16 Beta-ethyl-19-nortestosterone
3. 16 Ethyl-17-hydroxy-4-estren-3-one
4. Ehoo
5. Tsaa 291
6. Tsaa-291
7. Tsaa291
1. 33765-68-3
2. Prostetin
3. Tsaa-291
4. Mn4i850d4p
5. Ncgc00183854-01
6. (8r,9s,10r,13s,14s,16s,17s)-16-ethyl-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one
7. Oxendolona
8. Oxendolonum
9. (8r,9s,10r,13s,14s,16s,17s)-16-ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3h-cyclopenta[a]phenanthren-3-one
10. Oxendolonum [inn-latin]
11. Oxendolona [inn-spanish]
12. Unii-mn4i850d4p
13. Oxendolone [usan:inn:jan]
14. 16-beta-ethyl-19-nortestosterone
15. Prostetin (tn)
16. 16-ethyl-17-hydroxyester-4-en-3-one
17. Oxendolone [mi]
18. Oxendolone [inn]
19. Oxendolone [jan]
20. Oxendolone [usan]
21. 16beta-ethyl-17beta-hydroxyestr-4-en-3-one
22. Oxendolone [mart.]
23. 16-beta-ethyl-17-beta-hydroxyestr-4-en-3-one
24. Dsstox_cid_28740
25. Dsstox_rid_83009
26. Oxendolone [who-dd]
27. Dsstox_gsid_48814
28. Oxendolone (jan/usan/inn)
29. Schembl233297
30. Chembl513856
31. Dtxsid8048814
32. Chebi:31946
33. Estr-4-en-3-one, 16-ethyl-17-hydroxy-, (16-beta,17-beta)-
34. Zinc4217221
35. Tox21_113291
36. Akos016014084
37. Cas-33765-68-3
38. 16beta-ethyl-17beta-hydroxy-4-estren-3-one
39. 17beta-hydroxy-16beta-ethyl-4-estren-3-one
40. D01329
41. Q15633970
42. (16beta,17beta)-16-ethyl-17-hydroxyestr-4-en-3-one
43. Estr-4-en-3-one, 16-beta-ethyl-17-beta-hydroxy-
44. 16.beta.-ethyl-17.beta.-hydroxyestr-4-en-3-one
45. Estr-4-en-3-one, 16-ethyl-17-hydroxy-, (16beta,17beta)-
46. Allyl-2,3-di-o-benzyl-4,6-o-benzylidene-alpha-d-glucopyranoside
47. Estr-4-en-3-one, 16-ethyl-17-hydroxy-, (16.beta.,17.beta.)-
| Molecular Weight | 302.5 g/mol |
|---|---|
| Molecular Formula | C20H30O2 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 302.224580195 g/mol |
| Monoisotopic Mass | 302.224580195 g/mol |
| Topological Polar Surface Area | 37.3 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 508 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
47
PharmaCompass offers a list of Oxendolone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxendolone manufacturer or Oxendolone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxendolone manufacturer or Oxendolone supplier.
PharmaCompass also assists you with knowing the Oxendolone API Price utilized in the formulation of products. Oxendolone API Price is not always fixed or binding as the Oxendolone Price is obtained through a variety of data sources. The Oxendolone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A TSAA 291 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TSAA 291, including repackagers and relabelers. The FDA regulates TSAA 291 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TSAA 291 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A TSAA 291 supplier is an individual or a company that provides TSAA 291 active pharmaceutical ingredient (API) or TSAA 291 finished formulations upon request. The TSAA 291 suppliers may include TSAA 291 API manufacturers, exporters, distributors and traders.
click here to find a list of TSAA 291 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A TSAA 291 DMF (Drug Master File) is a document detailing the whole manufacturing process of TSAA 291 active pharmaceutical ingredient (API) in detail. Different forms of TSAA 291 DMFs exist exist since differing nations have different regulations, such as TSAA 291 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A TSAA 291 DMF submitted to regulatory agencies in the US is known as a USDMF. TSAA 291 USDMF includes data on TSAA 291's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The TSAA 291 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of TSAA 291 suppliers with USDMF on PharmaCompass.
TSAA 291 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of TSAA 291 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right TSAA 291 GMP manufacturer or TSAA 291 GMP API supplier for your needs.
A TSAA 291 CoA (Certificate of Analysis) is a formal document that attests to TSAA 291's compliance with TSAA 291 specifications and serves as a tool for batch-level quality control.
TSAA 291 CoA mostly includes findings from lab analyses of a specific batch. For each TSAA 291 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
TSAA 291 may be tested according to a variety of international standards, such as European Pharmacopoeia (TSAA 291 EP), TSAA 291 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (TSAA 291 USP).
